Last reviewed · How we verify
NCT06894615
EXOMIND (BTL-995) for the Reduction of Binge-eating
NA trial testing Treatment with BTL-995-rTMS in Binge Eating in 16 participants. Completed in 11 December 2023.
11 December 2023
Quick facts
| Lead sponsor | BTL Industries Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 11 July 2023 |
| Primary completion | 11 December 2023 |
| Estimated completion | 11 December 2023 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Treatment with BTL-995-rTMS
Conditions studied
- Binge Eating — all drugs for Binge Eating →
- Binge-Eating Disorder — all drugs for Binge-Eating Disorder →
Sponsor
BTL Industries Ltd. — full company profile →
Who can join
22 and older, any sex, with Binge Eating or Binge-Eating Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate if the treatment with the BTL-995-rTMS device is able to reduce binge eating in adults above the age of 22 years. The main question it aims to answer is: Whether the treatment with the BTL-995-rTMS device reduces binge eating. Participants will be asked to: * Undergo six treatments * Undergo weight measurements * Complete the Binge Eating Scale * Complete the Therapy Comfort Questionnaire * Complete the Satisfaction Questionnaire
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
ExoTMS transcranial magnetic stimulation for the reduction of binge eating symptoms.
Pánek D, Donchev TS. · · 2025 · PMID 40980699 · DOI 10.1002/pcn5.70200
Verify or expand the search:
- PubMed search for NCT06894615
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Treatment with BTL-995-rTMS
Trials testing the same drug.
- NCT06910592 — EXOMIND (BTL-995) for Reduction of Binge-eating · NA · completed
Other recruiting trials for Binge Eating
Currently open trials in the same condition.
- NCT06819813 — Project VIBE: Virtual Intervention for Binge Eating in Adolescents · NA · recruiting
- NCT05741125 — Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes · NA · recruiting
- NCT06528067 — Mindful Motivation for Reducing Binge Eating · NA · active not recruiting
- NCT06649994 — Transcranial Magnetic Stimulation and Inhibitory Control Training to Reduce Binge Eating: Brain and Behavioral Changes · NA · recruiting
- NCT06683456 — EMOTE: a Smartphone Application for Binge Eating Based on DBT Skills · NA · recruiting
Other BTL Industries Ltd. trials
Trials by the same sponsor.
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
- NCT07179224 — EEG Changes After rTMS Stimulation · NA · completed
- NCT07024550 — Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway · NA · active not recruiting
- NCT07027657 — EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06894615 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BTL Industries Ltd.
- Last refreshed: 17 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06894615.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing